Author:
He Qinghua,Wei Xuedong,Wu Eran,Luo Raoshan,Yu Lizhi,Liang Weiming
Abstract
Abstract
Purpose
To compare the efficacy and safety of micropercutaneous nephrolithotomy (MPCNL) and flexible ureteroscopy (FURS) in the treatment of single upper ureteral calculi measuring 1 to 2 centimeters.
Methods
This study is a retrospective analysis that combines a review of medical records with an outcomes management database. A total of 163 patients who underwent MPCNL and 137 patients who had FURS were identified between January 2017 and December 2021. Demographic data, operation time, hospitalization time, stone-free rate, and complication rate were collected and analyzed.
Results
Preoperative general data of sex, age, BMI, serum creatinine, time of stone existence, stone hardness, stone diameter, preoperative hydronephrosis, and preoperative infection of the MPCNL group have no statistically significant difference with that of the FURS group. All MPCNL or FURS operations in both groups were successfully completed without any instances of reoperation or conversion to another surgical procedure. Patients who underwent MPCNL had a considerably reduced operation time (49.6 vs. 72.4 min; P<0.001), but a higher duration of hospitalization (9.1 vs. 3.9 days; P<0.001) compared to those who underwent FURS. The stone-free rate in the MPCNL group was superior to that of the FURS group, with a percentage of 90.8% compared to 71.5% (P<0.001). There was no statistically significant disparity in the rate of complications between the two groups (13.5% vs. 15.3%; P = 0.741).
Conclusion
Both MPCNL and FURS are viable and secure surgical choices for individuals with solitary upper ureteral calculi measuring 1 to 2 cm. The FURS procedure resulted in a shorter duration of hospitalization compared to MPCNL. However, it had a comparatively lower rate of successfully removing the stones and required a longer duration for the operation.There were no substantial disparities observed in the complication rate between the two groups.FURS is the preferable option for treating uncomplicated upper ureteral calculi, whereas MPCNL is the preferable option for treating complicated upper ureteral calculi.Prior to making treatment options, it is crucial to take into account the expertise of surgeons, the quality of the equipment, and the preferences of the patient.
Trial registration
No.
Funder
the Scientific Research Foundation of Guangxi Health Commission
the Scientific Research Foundation of Guangxi University of Science and Technology
Publisher
Springer Science and Business Media LLC
Subject
Urology,Reproductive Medicine,General Medicine
Reference24 articles.
1. de Sousa Morais N, Pereira JP, Mota P, Carvalho-Dias E, Torres JN, Lima E. Percutaneous nephrostomy vs ureteral stent for hydronephrosis secondary to ureteric calculi: impact on spontaneous stone passage and health-related quality of life-a prospective study. Urolithiasis. 2019;47(6):567–73.
2. Wei YP, Lin XG, He RQ, Shen J, Sun SL, Chen G, Wang QY, Xu JF, Mo ZN. Epidemiologic Association of Nonalcoholic Fatty Liver Disease and urinary calculi: a Population-based cross-sectional study in Southern China. Iran J Kidney Dis. 2018;12(2):112–9.
3. Lai S, Jiao B, Jiang Z, Liu J, Seery S, Chen X, Jin B, Ma X, Liu M, Wang J. Comparing different kidney stone scoring systems for predicting percutaneous nephrolithotomy outcomes: a multicenter retrospective cohort study. Int J Surg. 2020;81:55–60.
4. El-Nahas AR, Nabeeh MA, Laymon M, Sheir KZ, El-Kappany HA, Osman Y. Preoperative risk factors for complications of percutaneous nephrolithotomy. Urolithiasis. 2021;49(2):153–60.
5. Cavildak IK, Nalbant I, Tuygun C, Ozturk U, Goksel Goktug HN, Bakirtas H, Imamoglu MA. Comparison of flexible ureterorenoscopy and laparoscopic ureterolithotomy methods for proximal Ureteric stones Greater Than 10 mm. Urol J. 2016;13(1):2484–9.